EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Development of a QSAR model for predicting PPARα activation by PFAS based on human in vitro data of a comprehensive panel of legacy and novel PFAS

Wiebke Alker, Periklis Tsiros, Haralambos Sarimveis, Albert Braeuning, Thorsten Buhrke iD

Archives of Toxicology · 2026

DOI: 10.1007/s00204-026-04359-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Archives of Toxicology, 2026. Verfasst von Wiebke Alker und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department Chemical and Product Safety, German Federal Institute for Risk Assessment (BfR), Max-Dohrn-Str. 8-10, 10589, Berlin, Germany. Hauptthemen laut MEDLINE: PPAR alpha, Quantitative Structure-Activity Relationship, Fluorocarbons, Environmental Pollutants. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 85 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Bundesinstitut für Risikobewertung (BfR).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Per- and polyfluoroalkyl substances (PFAS) are a large family of persistent environmental contaminants. Some PFAS are known to bioaccumulate, are frequently detected in human serum, and are associated with several adverse effects on the immune system, the endocrine system, and the liver. PFAS-mediated activation of the peroxisome proliferator-activated receptor alpha (PPARα), which plays a key role in lipid and cholesterol homeostasis, is suggested to be an important molecular initiating event triggering PFAS toxicity. The aim of this study was to evaluate the PPARα activation potential of a diverse panel of 34 PFAS congeners, consisting of both legacy and novel compounds, using a PPARα-dependent transactivation assay in transfected HEK293T cells. The resulting concentration-response data were analyzed using benchmark dose (BMD) modelling to quantify PPARα activation potency. A key finding was that PFAS with a sulfonic acid group showed a lower potency compared to those with a carboxylic group. The most potent activators belonged to the perfluoroalkylether carboxylic acid (PFECA) subgroup. Computational descriptors were generated to characterize each congener, and quantitative structure-activity relationship (QSAR) modelling was applied to relate molecular features to in vitro PPARα activation potency, as expressed by BMD estimates. For prioritization purposes in the context of PFAS hazard characterization, the QSAR model was used to screen about 10,000 PFAS congeners. Of these, roughly 10% were within the defined applicability domain of the developed QSAR model. Predicted BMD concentrations for PPARα activation were in the range between 0.3 µM and 420 µM.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PPAR alphaQuantitative Structure-Activity RelationshipFluorocarbonsEnvironmental PollutantsHumansHEK293 CellsDose-Response Relationship, Drug

Stichwörter der Autor:innen

BMDPFASPPARαQSAR

Substanzen

PPAR alphaFluorocarbonsEnvironmental PollutantsPPARA protein, human

Autor:innen und Institutionen

  • Department Chemical and Product Safety, German Federal Institute for Risk Assessment (BfR), Max-Dohrn-Str. 8-10, 10589, Berlin, Germany.
  • School of Chemical Engineering, National Technical University of Athens, 9 Iroon Polytechniou Str, 15772, Athens, Greece.
  • Department Chemical and Product Safety, German Federal Institute for Risk Assessment (BfR), Max-Dohrn-Str. 8-10, 10589, Berlin, Germany. thorsten.buhrke@bfr.bund.de.

ORCID-Profile: Thorsten Buhrke

Förderung

  • Bundesinstitut für Risikobewertung (BfR)

Zitieren

APA

Alker, W., Tsiros, P., Sarimveis, H., Braeuning, A., & Buhrke, T. (2026). Development of a QSAR model for predicting PPARα activation by PFAS based on human in vitro data of a comprehensive panel of legacy and novel PFAS. Archives of Toxicology. https://doi.org/10.1007/s00204-026-04359-2

Vancouver

Alker W, Tsiros P, Sarimveis H, Braeuning A, Buhrke T. Development of a QSAR model for predicting PPARα activation by PFAS based on human in vitro data of a comprehensive panel of legacy and novel PFAS. Archives of Toxicology. 2026. doi:10.1007/s00204-026-04359-2

BibTeX
@article{Alker2026,
  author = {Alker, Wiebke and Tsiros, Periklis and Sarimveis, Haralambos and Braeuning, Albert and Buhrke, Thorsten},
  title = {Development of a QSAR model for predicting PPARα activation by PFAS based on human in vitro data of a comprehensive panel of legacy and novel PFAS},
  journal = {Archives of Toxicology},
  year = {2026},
  doi = {10.1007/s00204-026-04359-2}
}
Kostenlos starten →